iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis

被引:0
|
作者
David C. Schöndorf
Massimo Aureli
Fiona E. McAllister
Christopher J. Hindley
Florian Mayer
Benjamin Schmid
S. Pablo Sardi
Manuela Valsecchi
Susanna Hoffmann
Lukas Kristoffer Schwarz
Ulrike Hedrich
Daniela Berg
Lamya S. Shihabuddin
Jing Hu
Jan Pruszak
Steven P. Gygi
Sandro Sonnino
Thomas Gasser
Michela Deleidi
机构
[1] German Center for Neurodegenerative Diseases (DZNE),Department of Neurodegenerative Diseases
[2] Hertie-Institute for Clinical Brain Research,Department of Medical Biotechnology and Translational Medicine
[3] University of Tübingen,Department of Cell Biology
[4] University of Milan,Department of Molecular Embryology
[5] Harvard Medical School,Department of Epileptology
[6] Emmy Noether-Group for Stem Cell Biology,undefined
[7] Institute of Anatomy and Cell Biology,undefined
[8] University of Freiburg,undefined
[9] Werner Reichardt Center for Integrative Neuroscience (CIN),undefined
[10] University of Tübingen,undefined
[11] Genzyme,undefined
[12] a Sanofi Company,undefined
[13] Hertie Institute for Clinical Brain Research,undefined
[14] University of Tübingen and German Center for Neurodegenerative Diseases,undefined
[15] Center for Biological Signaling Studies (BIOSS),undefined
[16] University of Freiburg,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in the acid β-glucocerebrosidase (GBA1) gene, responsible for the lysosomal storage disorder Gaucher’s disease (GD), are the strongest genetic risk factor for Parkinson’s disease (PD) known to date. Here we generate induced pluripotent stem cells from subjects with GD and PD harbouring GBA1 mutations, and differentiate them into midbrain dopaminergic neurons followed by enrichment using fluorescence-activated cell sorting. Neurons show a reduction in glucocerebrosidase activity and protein levels, increase in glucosylceramide and α-synuclein levels as well as autophagic and lysosomal defects. Quantitative proteomic profiling reveals an increase of the neuronal calcium-binding protein 2 (NECAB2) in diseased neurons. Mutant neurons show a dysregulation of calcium homeostasis and increased vulnerability to stress responses involving elevation of cytosolic calcium. Importantly, correction of the mutations rescues such pathological phenotypes. These findings provide evidence for a link between GBA1 mutations and complex changes in the autophagic/lysosomal system and intracellular calcium homeostasis, which underlie vulnerability to neurodegeneration.
引用
收藏
相关论文
共 50 条
  • [1] iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
    Schoendorf, David C.
    Aureli, Massimo
    McAllister, Fiona E.
    Hindley, Christopher J.
    Mayer, Florian
    Schmid, Benjamin
    Sardi, S. Pablo
    Valsecchi, Manuela
    Hoffmann, Susanna
    Schwarz, Lukas Kristoffer
    Hedrich, Ulrike
    Berg, Daniela
    Shihabuddin, Lamya S.
    Hu, Jing
    Pruszak, Jan
    Gygi, Steven P.
    Sonnino, Sandro
    Gasser, Thomas
    Deleidi, Michela
    NATURE COMMUNICATIONS, 2014, 5
  • [2] Investigating the pathogenesis of GBA1-associated Parkinson's disease (PD) using GBA1 isogenic iPSC lines
    Chen, Y.
    Chen, C.
    Ma, C.
    Lichtenberg, J.
    Hertz, E.
    Jong, T.
    Sam, R.
    Li, Y.
    Vrisjen, S.
    Vangheluwe, P.
    Blauwendraat, C.
    Sidransky, E.
    MOVEMENT DISORDERS, 2024, 39 : S414 - S414
  • [3] GBA1-Associated Parkinson's Disease Is a Distinct Entity
    Skrahin, Aliaksandr
    Horowitz, Mia
    Istaiti, Majdolen
    Skrahina, Volha
    Lukas, Jan
    Yahalom, Gilad
    Cohen, Mikhal E.
    Revel-Vilk, Shoshana
    Goker-Alpan, Ozlem
    Becker-Cohen, Michal
    Hassin-Baer, Sharon
    Svenningsson, Per
    Rolfs, Arndt
    Zimran, Ari
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [4] Generation of GBA1 isogenic iPSC lines to investigate the pathogenesis of GBA1-associated Parkinson disease
    Ma, Charis
    Chen, Yu
    Chen, Chase
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [5] iPSC-derived in vitro striatal circuits to understand GBA-associated Parkinson's disease
    Do, Quyen
    Ng, Bryan
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 96 - 97
  • [6] Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients
    Fernandez-Santiago, Ruben
    Carballo-Carbajal, Iria
    Castellano, Giancarlo
    Torrent, Roger
    Richaud, Yvonne
    Sanchez-Danes, Adriana
    Vilarrasa-Blasi, Roser
    Sanchez-Pla, Alex
    Luis Mosquera, Jose
    Soriano, Jordi
    Lopez-Barneo, Jose
    Canals, Josep M.
    Alberch, Jordi
    Raya, Angel
    Vila, Miquel
    Consiglio, Antonella
    Martin-Subero, Jose I.
    Ezquerra, Mario
    Tolosa, Eduardo
    EMBO MOLECULAR MEDICINE, 2015, 7 (12) : 1529 - 1546
  • [7] IPSC-Derived Cortical Neurons from Parkinson's Patients with VPS35 Mutation Show Defects in Synapto- and Neurogenesis
    Scheller, U.
    Lee, C. K.
    Seibler, P.
    Mitkovski, M.
    Rhee, J. S.
    van Riesen, C.
    MOVEMENT DISORDERS, 2024, 39 : S830 - S830
  • [8] MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients
    Tolosa, Eduard
    Botta-Orfila, Teresa
    Morato, Xavier
    Calatayud, Carles
    Ferrer-Lorente, Raquel
    Marti, Maria-Jose
    Fernandez, Manel
    Gaig, Caries
    Raya, Angel
    Consiglio, Antonella
    Ezquerra, Mario
    Fernandez-Santiago, Ruben
    NEUROBIOLOGY OF AGING, 2018, 69 : 283 - 291
  • [9] Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson's disease
    Mubariz, Fahad
    Saadin, Afsoon
    Lingenfelter, Nicholas
    Sarkar, Chinmoy
    Banerjee, Aditi
    Lipinski, Marta M.
    Awad, Ola
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [10] Parasympathetic Dysfunction Prevails in GBA1-Associated Parkinson's Disease
    De Santis, Tiziana
    Cocco, Antoniangela
    Castiglioni, Paolo
    Ferrarin, Maurizio
    Mineri, Rossana
    Morenghi, Emanuela
    Avenali, Micol
    Albanese, Alberto
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025, 12 (03): : 364 - 370